Ex Parte HORWITZ - Page 12




               Appeal No. 2002-1740                                                                                                 
               Application No. 08/447,398                                                                                           

                       Borremans is relied on for the disclosure of the gene and protein sequence of a                              
               32kD antigen from Mycobacterium tuberculosis.  Borremans found the 32 kD                                             
               extracellular protein to be a major stimulant of cellular and humoral immunity against                               
               mycobacterium (abstract).  Answer, page 7.                                                                           
                       Salata teaches a purified Mycobacterium 30kD extracellular protein.  From                                    
               guinea pig skin testing Salata concluded that the “30,000 dalton antigen of M.                                       
               tuberculosis may possess greater tuberculin sensitivity than PPD-S [tuberculin-purified                              
               protein derivative].”  Salata, page 594, column 2. Wallis teaches a purified                                         
               Mycobacterium 58kD extracellular protein, Verbon teaches purified Mycobacterium 24,                                  
               16 and 12kD extracellular proteins, Zhang teaches a purified Mycobacterium 23kD                                      
               extracellular protein, and Munk teaches purified Mycobacterium 71 and 12 kD                                          
               extracellular proteins.  Answer, pages 7-8.                                                                          
                       The examiner summarizes (Answer, page 8):                                                                    
                               It would have been obvious at the time the invention was made to a                                   
                       person having ordinary skill in the art to follow the teachings and                                          
                       suggestions of Pal et al concerning subunit vaccines by using individual,                                    
                       purified extracellular proteins of the other cited references in order to                                    
                       reduce any unwanted side effects caused by inclusion of components                                           
                       which may result in unwanted and/or unnecessary immune responses                                             
                       while providing an agent for vaccination.                                                                    
                       Upon review of the evidence of record, we agree that the examiner                                            
               has provided sufficient evidence to support a prima facie case of obviousness.   In                                  
               particular, Pal discloses a “purified”, e.g., isolated EP extracellular protein fraction from                        
               Mycobacterium tuberculosis.  The EP extracellular protein fraction was filtered,                                     
                                                                12                                                                  





Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007